Key Points
NEW YORK, Nov 10 (Reuters) - AstraZeneca (AZN.L) on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to prevent the disease in infants and toddlers, as a surge of cases is outpacing supply...
AstraZeneca CEO Pascal Soriot in an interview at the Reuters office in New York said the U.S. Centers for Disease Control and Prevention (CDC) had been asking for more of the antibody therapy that was co-developed with French drugmaker Sanofi (SASY.PA)...
Weve had to deliver what is needed (for the U.S.) and next year the volume suddenly will go up quite a bit, Soriot said, noting that the British drugmaker was seeing a surge in demand for the medicine "everywhere."..
RSV is the top cause of hospitalization among infants, leading to around 1% to 3% of children under 12 months of age being hospitalized in the United States each year, according to the American Academy of Pediatrics...
You might be interested in
CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
17, Nov, 23What is RSV affecting children this winter? Know about symptoms and treatment
24, Nov, 23Respiratory Syncytial Virus or RSV is a viral disease that infects young children. The disease shows mild symptoms but can be serious and lead to hospitalization of the patients. Young children and the elderly are more vulnerable to the virus.
Map shows states where West Nile virus has been detected in humans and mosquitos. The disease can cause a range of symptoms, from fever to brain swelling.
29, Jun, 23West Nile virus causes fever and other symptoms in about 1 in 5 cases, according to the CDC. It is the most common mosquito-borne disease in the US.
Flu cases increasing: What is driving the surge
17, Mar, 23Data from the Integrated Disease Surveillance Programme suggests that flu killed at least nine persons in January alone. Is it unusual for people to die of the flu? And what precautions should you take? We explain.
Just when we were starting to see COVID and RSV rates drop this spring, another type of virus contributed to a spike in respiratory infections
29, May, 23Symptoms of human metapneumovirus, or HMPV, include cough, fever, nasal congestion, and shortness of breath.
Babesiosis tick-borne disease symptoms, treatment as cases rise: CDC
17, Mar, 23Babesiosis effects can range from a mild illness with no symptoms to people getting severely sick with multi-organ failure.